Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D
Authors:
- Elizabeth A. ThomasETElizabeth A. Thomas
- Jeffrey K. YaoJYJeffrey K. Yao
- 1 January 2007
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 89 (1-3) , 147-153
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementationProstaglandins, Leukotrienes and Essential Fatty Acids, 2006
- Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatmentProstaglandins, Leukotrienes and Essential Fatty Acids, 2003
- Antipsychotic drugs differentially modulate apolipoprotein D in rat brainJournal of Neurochemistry, 2003
- Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patientsBiological Psychiatry, 2003
- Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcomeSchizophrenia Research, 2002
- 606: Clozapine: Elevation of membrane unsaturated lipid levels as a new mechanism of actionSchizophrenia Research, 1997
- Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjectsPsychiatry Research, 1996
- Arachidonic acid binds to apolipoprotein D: implications for the protein's functionFEBS Letters, 1995
- Immunologic and steroid binding properties of the GCDFP-24 protein isolated from human breast gross cystic disease fluidBreast Cancer Research and Treatment, 1990
- Binding properties of Progesterone-Binding Cyst Protein, PBCPSteroids, 1988